Article
Mpox vaccine and infection-driven human immune signatures
2023-03-09
Abstract excerpt
<h4>Background</h4> Mpox (formerly known as monkeypox) outbreaks outside endemic areas peaked in July 2022, infecting > 85,000 people and raising concerns about our preparedness against this emerging viral pathogen. Licensed and approved for mpox, the JYNNEOS vaccine has fewer side effects than previous smallpox vaccines and demonstrated efficacy against mpox infection in humans. Comparing JYNNEOS vaccine- and mpo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e25f46b5-3fa8-5463-b37d-6a3731e1c575
- DOI
- 10.1101/2023.03.07.23286701
